Korean scientists embarks on more intensive stem cell research

Published: 2004-04-14 06:57:00

Updated: 2004-04-14 06:57:00

Stimulated by the announcement that Hwang Woo-suk and Moon shin-yong of Seoul National University have become the first in the world to successfully clone a human embryo and then culled stem cell from it, domestic research-oriented pharmaceutical firms and start-up companies, such as Samjin Pharm...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK